Intrinsic Value of S&P & Nasdaq Contact Us

argenx SE ARGX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$973.18
+17.5%
Analyst Price Target
$1,026.71
+23.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

argenx SE (ARGX) trades at a trailing P/E of 42.6, forward P/E of 31.3. Trailing earnings yield is 2.35%, forward earnings yield 3.20%. PEG 0.80 (Peter Lynch undervalued ≤1.0). Graham Number is $222.07.

Criteria proven by this page:

  • VALUE (52/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 31.3 (down from trailing 42.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.80 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 2.35% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.20% as earnings recover.
  • Analyst consensus target $1,026.71 (+23.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 80/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
80/100
SG Score
View full scorecard →
~
VALUE
52/100
Price-to-Earnings & upside
Proven by this page
FUTURE
88/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — ARGX

Valuation Multiples
P/E (TTM)42.6
Forward P/E31.3
PEG Ratio0.80
Forward PEG0.89
P/B Ratio6.57
P/S Ratio14.35
EV/EBITDA46.6
Per Share Data
EPS (TTM)$18.38
Forward EPS (Est.)$26.50
Book Value / Share$119.25
Revenue / Share$55.00
FCF / Share$12.09
Yields & Fair Value
Earnings Yield2.35%
Forward Earnings Yield3.20%
Dividend Yield0.00%
Graham Number$222.07
SharesGrow IV$973.18 (+17.5%)
Analyst Target$1,026.71 (+23.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -19.3 -1.57 6.49 27.97 -
2017 -46.6 -3.08 3.79 35.91 -
2018 -45.3 -0.83 5.61 140.65 -
2019 -34.2 -0.28 5.25 79.01 -
2020 -21.9 -0.12 7.98 323.80 -
2021 -43.9 1.09 7.06 35.97 -
2022 -29.0 -0.46 7.32 50.16 -
2023 -73.7 1.22 5.31 17.74 -
2024 44.2 -0.12 6.70 16.81 -
2025 39.8 0.77 7.04 12.38 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.20 $15.47M $-22.48M -145.3%
2017 $-1.37 $43.69M $-33.68M -77.1%
2018 $-2.12 $24.57M $-76.23M -310.2%
2019 $-4.69 $78.46M $-181.21M -231%
2020 $-13.40 $41.24M $-608.46M -1475.3%
2021 $-7.99 $497.28M $-407.63M -82%
2022 $-13.05 $410.75M $-709.59M -172.8%
2023 $-5.16 $1.23B $-295.05M -24.1%
2024 $12.78 $2.19B $833.04M 38%
2025 $19.63 $4.16B $1.3B 31.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $26.50 $17.12 – $33.19 $5.96B $5.53B – $6.43B 13
2027 $34.71 $23.91 – $42.46 $7.17B $6.41B – $8.08B 13
2028 $46.00 $40.09 – $52.23 $8.59B $7.74B – $9.48B 9
2029 $53.37 $46.51 – $60.61 $9.77B $8.81B – $10.79B 11
2030 $59.25 $51.64 – $67.28 $11.01B $9.92B – $12.15B 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message